Clinical research: As part of the science sessions “Lab confidential - What's red hot from the men in white coats,” held on Tuesday, Feb. 4, at noon, Dr. Stéphanie-Anne Girard, clinical program manager, will unveil a new clinical study conducted with three of Lallemand’s probiotic strains on more than 500 subjects: “The effect of probiotics on immune function and digestive health in academically-stressed university students: a randomized, double blind, placebo controlled study.”

Health claims and regulation: Solange Henoud, regulatory affairs manager, will present “Health Claim Success! The Lallemand experience in Canada,” on Wednesday, Feb. 5, at 10 a.m. In 2013, the granting by the Canadian Heath Authorities (NHPD) of six condition-specific Health Claims in the areas of digestive health, natural defenses and stress for some of the company’s key probiotic formulas, was a major achievement for Lallemand Health Solutions. Mrs. Henoud was invited to share this experience and explore the process which led to the successful claims, as well as consider the implications for claims made in other jurisdictions such as the EU.